A highly mutated COVID variant called BA.2.86 has now been detected in Switzerland and South Africa in addition to Israel, Denmark, the U.S. and the U.K., according to a leading World Health Organization official.

Roche

Roche’s Genentech on Thursday released early-stage data on its KRAS inhibitor, divarasib,  as it hopes to join Amgen and Mirati in the potential blockbuster cancer market. 

Johnson & Johnson appears to be winding down research at its infectious disease and vaccine unit, save for a few select programs, according to Fierce Biotech on Wednesday, citing sources familiar with the matter.

After being flagged for safety concerns in July, Apellis has now identified the needle as a possible cause of the cases of severe eye inflammation in patients receiving the company’s recently approved geographic atrophy injection.

Roche

Roche inadvertently published positive lung cancer drug trial data from an interim analysis, boosting the Swiss drug maker’s shares even though more data will be needed to confirm the treatment’s efficacy.

The U.S. government said on Tuesday it had awarded $1.4 billion for the development of new therapies and vaccines against COVID-19, including a $326 million contract with Regeneron Pharmaceuticals or a next-generation antibody therapy for prevention of infections.

Novavax

Novavax Inc. said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against emerging forms of coronavirus such as the “Eris” subvariant in small studies in animals.

Pfizer

The U.S. Food and Drug Administration on Monday approved Pfizer’s (PFE.N) respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Moderna

Moderna and China’s CARsgen Therapeutics are collaborating to combine their respective mRNA therapeutic cancer vaccine with a solid tumor CAR T cell therapy, the Chinese biotech announced on Monday.

The FDA has established a voluntary pilot program intended to address the risks when targeted cancer treatments are approved without a companion diagnostic.